Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?
Agentic AI Powers U.S. Healthcare Stocks
Evolent Health Q1 Earnings Call Highlights
Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript
Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics
Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates
Evolent Announces First Quarter 2026 Results
Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026
Evolent Health, Inc (NYSE:EVH) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Evolent announces appointment of Archie Mayani as chief product officer
8 Knots Management LLC Lowers Position in Evolent Health, Inc $EVH
Evolent to Participate in Upcoming Investor Conferences
Evolent Health: Cheap, Levered, But Ready To Rebound
Evolent Health, Inc. (EVH) Q4 2025 Earnings Call Transcript
Compared to Estimates, Evolent Health (EVH) Q4 Earnings: A Look at Key Metrics
Evolent Health (EVH) Q4 Earnings Top Estimates
Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results
Evolent Health (NYSE:EVH) Share Price Crosses Below Fifty Day Moving Average – Should You Sell?
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026
Evolent Health, Inc (NYSE:EVH) Given Consensus Recommendation of “Moderate Buy” by Analysts
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08
Is the Options Market Predicting a Spike in Evolent Health Stock?
Evolent Health, Inc. (EVH) Presents at UBS Global Healthcare Conference 2025 Transcript
Evolent Health, Inc. (EVH) Q3 2025 Earnings Call Transcript
Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics
Evolent Health (EVH) Misses Q3 Earnings Estimates
Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden
Evolent Announces Third Quarter 2025 Results
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners
CVS vs. EVH: Which Value-Based Care Stock Deserves Investor Attention?
Evolent's Soft Q2 Results: Why I'm Holding Anyway
Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
Evolent Health, Inc. (EVH) Q2 2025 Earnings Call Transcript
Evolent Health (EVH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Evolent Health (EVH) Reports Q2 Loss, Misses Revenue Estimates
EVH Earnings Drop 31%
Evolent Announces Second Quarter 2025 Results
Earnings Preview: Evolent Health (EVH) Q2 Earnings Expected to Decline
Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
Evolent announces key appointments to leadership team
Evolent Health (EVH) Stock Jumps 6.9%: Will It Continue to Soar?
Evolent reiterates Q2 and full year guidance for Adjusted EBITDA
Evolent Health, Inc. (EVH) Q1 2025 Earnings Call Transcript
Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say
Evolent Health (EVH) Q1 Earnings Lag Estimates
Evolent Announces First Quarter 2025 Results
Wall Street Analysts Believe Evolent Health (EVH) Could Rally 53.33%: Here's is How to Trade
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors